A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2013-05-24
Summary
Patients with head and neck cancer and are schedule to receive standard radiation therapy known as IMRT to treat cancer
Conditions
Interventions
- RADIATION
-
IMRT
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Wade Thorstad, MD · Washington University School of Medicine
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2008-01-31
- Completion
- 2008-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.
NCT01427010 ·Status: COMPLETED ·Phase: NA
-
Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.
NCT01341535 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck
NCT00363441 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients
NCT03588403 ·Status: UNKNOWN
-
Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer
NCT01576939 ·Status: COMPLETED ·Phase: NA
-
Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck
NCT01287390 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers
NCT02068313 ·Status: UNKNOWN
-
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
NCT04477759 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
NCT00406289 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
NCT06137274 ·Status: RECRUITING ·Phase: PHASE2
-
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
NCT06487403 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.
NCT01730651 ·Status: UNKNOWN ·Phase: NA
-
INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy
NCT03953976 ·Status: COMPLETED ·Phase: PHASE2
-
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
NCT01836692 ·Status: COMPLETED ·Phase: NA
-
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
NCT02795195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers
NCT04242459 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)
NCT01220752 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy
NCT01709006 ·Status: TERMINATED ·Phase: NA
-
BNCT and IG-IMRT for Recurrent Head and Neck Cancer
NCT02004795 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI
NCT05160714 ·Status: UNKNOWN ·Phase: PHASE1
-
Radiotherapy of Head and Neck Cancer With SIB
NCT06831903 ·Status: RECRUITING
-
Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
NCT00004226 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
NCT03224000 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adaptive Radiation Therapy for Head & Neck Cancer Patients
NCT01853670 ·Status: COMPLETED ·Phase: NA